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ABSTRACT 
We describe a 54-year-old woman with isolated pulmonary arterial hypertension accompanied by hyperthyroidism 
due to Graves’ disease. Her pulmonary artery hypertension resolved spontaneously after restoration of euthyroid-
ism. This case suggests that hyperthyroidism should be considered a reversible cause of pulmonary arterial hy-
pertension. (Korean Circ J 2009;39:168-170) 
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Introduction 
 
Hyperthyroidism affects the cardiovascular system in 
many ways. It increases heart rate and cardiac mass, 
promotes cardiac arrhythmias, and elevates systolic blood 
pressure. It also shortens the ejection period and im-
pairs diastolic function.
1)2) Rarely, pulmonary hyperten-
sion has been reported in association with hyperthy-
roidism.
3)4) We report a patient with isolated pulmonary 
arterial hypertension accompanied by hyperthyroidism 
due to Graves’ disease. The pulmonary hypertension re-
solved spontaneously with restoration of euthyroidism. 
 
Case 
 
A 54-year-old woman was admitted to the emergency 
room with dyspnea and generalized edema. Physical ex-
amination revealed diaphoresis, jaundice, distended 
jugular veins, hepatomegaly, ascites, ankle edema, and 
decreased breath sounds in both lower lung fields. A 
chest roentgenogram showed marked cardiomegaly and 
bilateral pleural effusions. Laboratory tests revealed leu-
kocytosis without neutrophilia, normal cellular liver en-
zymes {aspartate aminotransferase (AST)/alanine ami-
notransferase (ALT) of 16/12 IU/L}, mild bilirubinae-
mia (total bilirubin of 3.4 mg/dL), a prolonged pro-
thrombin time of 17.7 seconds {international normalized 
ratio (INR) 1.7}, and a normal partial prothrombin time 
of 28 seconds. The patient was given oxygen through 
nasal cannula and was administered intravenous fur-
osemide for pulmonary congestion. She underwent a 
transthoracic echocardiogram, which revealed a dilated 
right ventricle, reduced right ventricular systolic func-
tion, a severely elevated systolic pulmonary arterial pres-
sure of 80 mmHg, and moderate tricuspid valvular regur-
gitation. The left ventricular chamber was normal sized, 
with a reasonable ejection fraction of 0.75 (Fig. 1A). Se-
rum D-dimer was elevated at 2,460 ng/mL (normal, 0-
500 ng/mL). A chest computed tomogram obtained to 
rule out pulmonary embolism revealed no evidence of 
pulmonary embolism. A ventilation-perfusion pulmo-
nary scan suggested a low probability of pulmonary em-
bolism, as well. At this point, chest CT suggested the 
possibility of thyroid goiter (Fig. 2). Further laboratory 
tests revealed a decreased serum thyroid-stimulating 
hormone (TSH) level (less than 0.08 uIU/mL), an in-
creased serum free thyroxine (FT4) level (4.45 ng/dL; 
normal, 0.89-1.76 ng/dL), and an increased serum 
total triiodothyronine (TT3) level (3.03 ng/mL; normal, 
0.60-1.81 ng/mL). A right heart catheterization per-
formed the following day demonstrated severely ele-
vated systolic/mean pulmonary artery hypertension of 
80/60 mmHg. The pulmonary capillary wedge pres-
sure was normal at 10 mmHg, without evidence of in-
tracardiac shunt. Anti-thyroid peroxidase antibodies 
were positive at 54.7 U/mL. The patient was confirmed 
to have idiopathic pulmonary artery hypertension and 
hyperthyroidism due to Grave’s disease and was started 
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on bosentan, amlodipine, and methimazole. During 
the following days, the patient’s clinical condition grad-
ually improved, and her body weight returned to base-
line. The patient was discharged in good clinical con-
dition without signs or symptoms of heart failure. TSH 
was still low (<0.08 uIU/mL), and TT3 was slightly 
elevated (2.53 ng/mL), but FT4 was within the normal 
laboratory range (1.63 ng/dL).  
Approximately four weeks later, a transthoracic echo-
cardiogram revealed a normal sized right ventricle with 
good systolic function, improved systolic pulmonary 
artery pressure of 35 mmHg, and trivial tricuspid val-
vular regurgitation (Fig. 1B).  
TT3 improved (2.28 ng/mL), and FT4 remained in 
the normal range (1.34 ng/dL). We decided to discon-
tinue bosentan, which is capable of masking the effect 
of the euthyroid state. After discontinuation of bo-
sentan, the patient remained in good condition, with-
out symptoms or signs of right-sided heart failure. Six 
months later, the patient had normal pulmonary ar-
tery pressure. She remained euthyroid on methimazole 
(Table 1). 
 
Discussion 
 
Many of the clinical manifestations of hyperthyroid-
ism are attributable to the ability of thyroid hormones 
to alter cardiovascular hemodynamics. The usual man-
ifestations occur secondary to high cardiac output caus-
ing left-sided heart failure. However, there is an increas-
ing body of evidence suggesting that hyperthyroidism 
Table 1. Pulmonary arterial systolic pressure gradually returned 
to normal in accord with the restoration of thyroid function 
  PA systolic 
pressure (mmHg) 
TR  FT4 
(ng/dL) 
Bosentan 
On admission  80 GII/IV  4.45  On 
2 weeks after 
admission 
80 GII/IV  2.68  On 
4 weeks after 
admission 
38 Trivial  1.34  Off 
9 weeks after 
admission 
25 Trivial    Off 
PA: pulmonary artery, TR: tricuspid regurgitation, FT4: free thyroxin
 
A 
B 
Fig. 1. Echocardiography in a patient with isolated pulmonary arterial hypertension accompanied by hyperthyroidism. A: echocardio-
graphy on admission. The right atrium is markedly enlarged, and the right ventricle is compressing the left ventricle into a D-shape. The 
left ventricle is normal-sized. B: echocardiography after restoration of euthyroid state. The right atrial and ventricular sizes have nor-
malized after resolution of hyperthyroidism. RV: right ventricle, LV: left ventricle, RA: right atrium, LA: left atrium. 
Fig. 2. Chest computed tomography on admission. The thyroid
gland is enlarged (white arrow), suggesting abnormal thyroid
function.  
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might cause reversible pulmonary arterial hypertension 
(PAH), resulting in right-sided heart failure. This ph-
enomenon might be underdiagnosed, because pulmo-
nary artery pressure usually returns to the normal range 
after a euthyroid state is achieved.
5) The potential pa-
thogenic mechanisms of hyperthyroidism-related PAH 
remain unclear. It has been postulated that the patho-
genesis of PAH in hyperthyroid patients is similar to 
that of other autoimmune diseases related to PAH.
6) 
However, Siu et al.
7) reported that there was no signifi-
cant difference in the prevalence of positive autoimmune 
antibodies between patients with PAH and those with-
out PAH, or in the resolution of PAH after successful 
antithyroid treatment regardless of the underlying etio-
logy of hyperthyroidism. It is uncertain which sub-group 
of patients is inclined to develop PAH. However, PAH 
obviously develops in some patients. Therefore, it is cru-
cial to recognize hyperthyroidism as a reversible cause 
of PAH. 
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